Based on the information provided in the URL, I have created a product description for the Anti-IL17RA/Brodalumab Biosimilar MAB (HDBS0038):The Anti-IL17RA/Brodalumab Biosimilar MAB (HDBS0038) is a monoclonal antibody designed for research involving IL17RA, a cell surface receptor known for its role in inflammation and immune regulation. This biosimilar antibody, developed as a potential alternative to brodalumab, is highly specific and reactive with human samples, making it a valuable tool for studying the IL17RA pathway in various cell types.IL17RA is a key player in the immune response, particularly in autoimmune diseases and chronic inflammatory conditions. By targeting IL17RA, researchers can explore potential therapeutic strategies for treating conditions such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease.
The Anti-IL17RA/Brodalumab Biosimilar MAB (HDBS0038) enables precise detection and analysis of IL17RA in biological samples, providing insights that can drive drug development and personalized medicine approaches. Overall, this biosimilar monoclonal antibody offers a reliable and validated solution for studying the IL17RA pathway and its involvement in immune-mediated disorders, paving the way for innovative research and therapeutic advancements in immunology and inflammatory disease management.
Product Name:
Brodalumab (Anti-IL17RA) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0038
Target:
IL17RA
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
AMG827, KHK4827
Description:
Anti-IL17RA (brodalumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG2
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
